Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CQ Pharmaceutical Holding CoSZSE:000950 77 Current Ratio is 1.19 as of Jun. 2026, which is 8% below its 10-year median of 1.29. GuruFocus rates SZSE:000950 with a GF Score™ of 77/100 and a GF Value™ of ¥5.68 (Fairly Valued). The stock has 8 warning signs investors should review. Among 124 Medical Distribution companies, CQ Pharmaceutical Holding Co ranks worse than 71.77% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. CQ Pharmaceutical Holding Co's current ratio for the quarter that ended in Jun. 2026 was 1.19.
CQ Pharmaceutical Holding Co has a current ratio of 1.19. It generally indicates good short-term financial strength.
The historical rank and industry rank for CQ Pharmaceutical Holding Co's Current Ratio or its related term are showing as below:
SZSE:000950'
s Current Ratio Range Over the Past 10 Years
Min: 0.32 Med: 1.29 Max: 1.6
Current: 1.19
During the past 13 years, CQ Pharmaceutical Holding Co's highest Current Ratio was 1.60. The lowest was 0.32. And the median was 1.29.
SZSE:000950's Current Ratio is ranked worse than 71.77% of 124
companies
in the Medical Distribution industry
Industry Median: 1.45
vs SZSE:000950: 1.19
CQ Pharmaceutical Holding Co (SZSE:000950) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
CQ Pharmaceutical Holding Co Current Ratio Related Terms
CQ Pharmaceutical Holding Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SZSE:000950 vs MCK, COR, CAH: Current Ratio Comparison
For the Medical Distribution subindustry, CQ Pharmaceutical Holding Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CQ Pharmaceutical Holding Co Current Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, CQ Pharmaceutical Holding Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where CQ Pharmaceutical Holding Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CQ Pharmaceutical Holding Co (SZSE:000950) has a Current Ratio of 1.19 as of Jun. 2026. This is near median its historical median of 1.29. Over the past decade, CQ Pharmaceutical Holding Co's Current Ratio has ranged from 0.32 to 1.60. According to the industry distribution chart, CQ Pharmaceutical Holding Co ranks #89 out of 124 companies in the Medical Distribution industry, placing it in the top 71.8%.
Is CQ Pharmaceutical Holding Co's Current Ratio too high?
CQ Pharmaceutical Holding Co's current Current Ratio of 1.19 is near median its 10-year median of 1.29. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 1.60. The Medical Distribution industry median Current Ratio is 1.45. CQ Pharmaceutical Holding Co's value of 1.19 is 17.9% below this industry median. Based on the distribution chart, CQ Pharmaceutical Holding Co ranks #89 out of 124 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, CQ Pharmaceutical Holding Co has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CQ Pharmaceutical Holding Co's Current Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, CQ Pharmaceutical Holding Co ranks #89 out of 124 companies for Current Ratio. This places CQ Pharmaceutical Holding Co in the lower half of its industry. The industry median Current Ratio is 1.45. CQ Pharmaceutical Holding Co's value of 1.19 is 17.9% below this benchmark. Historically, CQ Pharmaceutical Holding Co's own Current Ratio has ranged from 0.32 to 1.60 over the past decade. While the company's 10-year median is 1.29 vs. the industry median of 1.45, CQ Pharmaceutical Holding Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Distribution company?
The median Current Ratio among Medical Distribution companies is 1.45, based on 124 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CQ Pharmaceutical Holding Co's current Current Ratio of 1.19 is 17.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median Current Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CQ Pharmaceutical Holding Co's current Current Ratio is 1.19, which is near median its own 10-year median of 1.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CQ Pharmaceutical Holding Co stock overvalued right now?
Based on GuruFocus' analysis, CQ Pharmaceutical Holding Co (SZSE:000950) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.68, compared to a current price of ¥5.17 — trading 9% below its estimated fair value. The current Current Ratio is 1.19, which is near median its 10-year median of 1.29 and 17.9% below the Medical Distribution industry median of 1.45. CQ Pharmaceutical Holding Co's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For CQ Pharmaceutical Holding Co (SZSE:000950), the current Current Ratio is 1.19 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CQ Pharmaceutical Holding Co (SZSE:000950) Overvalued in 2026?
Based on GuruFocus' analysis, CQ Pharmaceutical Holding Co stock appears to be undervalued.
The current stock price of ¥5.17 is trading 9% below its estimated GF Value™ of ¥5.68.
GuruFocus considers CQ Pharmaceutical Holding Co to be Fairly Valued.
Key valuation signals for SZSE:000950:
Current Ratio: 1.19 (near median its 10-year median of 1.29)
GF Value™: ¥5.68 vs. price of ¥5.17 (9% below fair value)
Industry Position: 17.9% below the Medical Distribution median (#89 of 124)
No single metric tells the full story. See the SZSE:000950 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CQ Pharmaceutical Holding Co Ltd distributes pharmaceutical products. It is the fixed-point reserve unit for drug and medical equipment of the central and Chongqing industries. The pharmaceutical business sector covers hospitals, pharmaceuticals, healthcare products, hospital sales, commercial wholesale, retail chains, terminal distribution, warehousing logistics and supply chain value-added services. Geographically, the group operates through China.
77GF Score
Get the complete analysis for SZSE:000950
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:000950 has been successfully added to your 
